Sale!

Research Paper on Patients with non-small cell lung cancer’s proteomic biomarkers

Original price was: ₹21,240.00.Current price is: ₹10,620.00. inc. GST

Research Paper on Patients with non-small cell lung cancer’s proteomic biomarkers

1 in stock

Description

Title: Patients with non-small cell lung cancer’s proteomic biomarkers

Abstract: The 5-year survival rate for lung cancer is extremely low (6–13%) in all of the world’s countries. Non-small cell lung cancer is the histological subtype of this cancer that is most frequently diagnosed (NSCLC). The fact that patients are diagnosed with lung cancer in its advanced stages is primarily to blame for the poor prognosis for the disease, which includes NSCLC. The goal of this study is to compile information on fresh lines of inquiry into diagnostic biomarkers that could aid in the routine diagnosis of this cancer. Proteomic analysis has recently developed into a crucial tool for cancer biology research, working in tandem with genetic analysis. Mass spectrometry techniques are one of the many proteomic analysis techniques that allow for the highly precise qualitative and quantitative identification of hundreds of proteins in small volumes of various biological samples. These analyses might soon serve as the foundation for better lung cancer diagnostic techniques. The most recent reports on proteomic research related to the diagnosis of NSCLC are presented in this study. We present new potential proteomic biomarkers whose presence suggests the early onset of a neoplastic process. We outline biomarkers whose altered expression levels correspond with various cancer-related stages. Additionally, we offer protein biomarkers that aid in distinguishing NSCLC subtypes. Making an early diagnosis of NSCLC patients is crucial, but it’s also crucial to keep an eye on how the neoplastic disease is progressing. Given this information, we also provide examples of biomarkers whose abnormal expression may point to a high risk of lymph node metastasis. The importance of conducting additional research to confirm the usefulness of the described biomarkers in clinical practice is also emphasized in this paper.

Keywords: non–small cell lung cancer, proteomic biomarker, mass spectrometry

Paper Quality: SCOPUS / Web of Science Level Research Paper

Subject: Advances in Respiratory Medicine

Writer Experience: 20+ Years

Plagiarism Report: Turnitin Plagiarism Report will be less than 10%

Restriction: Only one author may purchase a single paper. The paper will then indicate that it is out of stock.

What will I get after the purchase?

A turnitin plagiarism report of less than 10% in a pdf file and a full research paper in a word document.

In case you have any questions related to this research paper, please feel free to call/ WhatsApp on +919726999915

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.